ArticleCureus2025
Atypical Anti-glomerular Basement Membrane Disease in a 16-Year-Old Male Child: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-glomerular basement membrane (anti-GBM) disease is an extremely rare small vessel vasculitis, which typically presents as rapidly progressive glomerulonephritis with or without pulmonary hemorrhage. Atypical anti-GBM disease varies in its clinical and laboratory presentation with insidious onset of symptoms. We present the case of a 16-year-old male child who presented with a two-week history of fever, weight loss, cough, hemoptysis, shortness of breath, and a five-year history of intermittent emesis. A computerized tomography of the chest demonstrated diffuse miliary pulmonary nodules with a "tree-in-bud" pattern. Serologic evaluation was negative for anti-nuclear, double-stranded, and anti-neutrophilic cytoplasmic antibodies. Urinalysis was negative for hematuria and proteinuria, but anti-GBM antibodies were elevated. Kidney biopsy demonstrated linear immunofluorescence staining of glomerular basement membrane with immunoglobulin G (IgG) without active crescent formation or necrosis. Lung biopsy demonstrated occasional hemosiderin-laden macrophages, patchy peribronchial and interstitial lymphocytic inflammation, interstitial and alveolar septal fibrosis, and emphysema. The patient was diagnosed with atypical anti-GBM disease based on the circulating and tissue-bound antibodies on kidney and lung biopsy and chronic alveolar bleeding, and improved with treatment with intravenous steroids, cyclophosphamide, and rituximab. This case report highlights the importance of a high index of suspicion for this disease and the need to perform a renal biopsy even in the absence of hematuria or proteinuria. Additionally, this case was unusual as the patient presented primarily with pulmonary and gastrointestinal symptoms and normal renal functions. His pathology was limited to linear immunofluorescence without active crescent formation, and this has not been previously reported, to our knowledge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.